The emphasis must be put on how to get it done, not why it is so difficult. This is not an economic argument (although it will help massively), but simply about healthcare resources and fatalities.
Far better to spend a relatively small amount of resource (money and time) to vaccinate, than a much larger amount treating those who get infected, and who even after hospital and ICU may ultimately die. This is particularly true for the vulnerable and elderly who seem to be the priority group.
I do not believe it is an impossibility - if Nightingales can be built in a few weeks, testing ramped up 50 fold in six months, vaccines developed in less than 20% of notrmal times - this is really just a moderate challenge to get control of the virus.
|